Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript May 9, 2024

Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.008 EPS, expectations were $0.96. RPRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma First Quarter 2024 Earnings Conference Call. I would like now to turn the conference over to George Grofik,...